Sepsis Diagnostics Market Forecast to 2028

Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarray), Flow Cytometry, Microfluidics, Immunoassay, Biomarker, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

Report Code : TIPHE100001391 | Region : Global | Industry : Medical Device | Published Date : 29/Dec/2022

The global sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028. Factors such as the rising incidence of sepsis due to increasing nosocomial infections and growing demand for rapid diagnostic tests leading to increasing product launches drive the overall growth of the sepsis diagnostics market. However, the lack of skilled professionals hampers the sepsis diagnostics market growth.

Sepsis is the body's extreme response to an infection. Sepsis is a serious clinical condition that can be a result of other infections, including viral infections, such as COVID-19 or influenza. It is a life-threatening medical emergency. Early detection and specific clinical intervention are crucial for improving the outcome of patients suffering from sepsis. Sepsis caused by bacteria involves cascade of reactions, such as lack of oxygen supply to cells and inactivation of immune complexes involved in the clearance of bacteria and its particles, which progresses to multiple organ failure. Sepsis is considered as a three staged syndrome by many physicians that starts with sepsis, leading to severe sepsis, and results in septic shock, which is considered as a medical emergency. Sepsis has a high mortality and morbidity rate. Sepsis diagnostics is the study of diagnosis of sepsis, which is a serious clinical condition that generally results from primary bacterial infection or, less frequently, from a fungal and/or viral infection. According to an article published by the National Center for Biotechnology Information in February 2019, the mortality rate of sepsis is 25 % to 30 %.

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. As a result, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. For instance, in September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform replaces the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. Additionally, in May 2020, Beckman Coulter launched its new DxH 690T hematology analyzer with early sepsis indicators in the US.

Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. For instance, Inflammatix, a pioneering molecular diagnostics company, published a health economic model that shows the use of the company's HostDxTM Sepsis test is cost-effective as compare to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in Emergency Departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test.

Furthermore, the rising need for rapid diagnostics for sepsis fueled the research activities among key players in recent years. Both the existing players and the start-ups in sepsis diagnostics are well supported financially by government and research organizations. For instance, in April 2020, Cytovale Inc. partnered with the Biomedical Advanced Research and Development Authority (BARDA) for sepsis diagnosis in patients with respiratory infections, including COVID-19. The research was estimated to stand at US$ 5.9 million, with a contribution of approximately US$ 3.83 million by BARDA. Thus, the launch of effective treatments and ongoing clinical trials would provide lucrative opportunities for the sepsis diagnostics market during the forecast period.

The global sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, and end user. Based on product, the sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment is estimated to account for the largest market share during 2021–2028. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points toward further investigations for identifying the focus on infection. A blood culture media is recommended for all septic patients. Automation in the blood culture system has enabled maximum yield of pathogens in the shortest possible time to improve patient management and save lives. The method is highly recommended as it reveals one of the highest levels of evidence in the diagnostic workup of a sepsis patient. Such aforementioned factors support the market growth for the blood culture media segment and ultimately fuel the growth of sepsis diagnostics market.

The software segment is expected to register the highest CAGR for the overall sepsis diagnostics market during the forecast period. Several top players involved in the global sepsis diagnostics market continuously launch different software to stay forefront in the market. For instance, Mobile Technology announced the launch of Nerve center Software that play an important role in early detection of sepsis and other life-threatening conditions among patients. The new software uses vital signs and pathology results for automating the early diagnosis of sepsis and then ensures that the appropriate doctors and nurses are immediately alerted on their mobile devices when a risk of sepsis has been identified.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Library of Medicine, and National Center for Biotechnology Information (NCBI) are among the primary and secondary sources referred to while preparing the report on the global sepsis diagnostics market.

Sepsis Diagnostics Market for Blood Culture Media Segment to Grow Significantly During 2021–2028

According to our new research study on "Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Technology, Method, Test Type, Pathogen, and End User," the market is expected to grow from US$ 661.83 million in 2021 to US$ 1,226.52 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. The report highlights trends prevailing in the market and factors governing the growth of the market. Rising demand for rapid diagnostic tests leading to increasing product launches is expected to accelerate the overall sepsis diagnostics market revenue during the forecast period. However, the lack of skilled professionals limits the market growth.

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. To fulfill this rising demand, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. For instance, in September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform aimed to replace the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. The cost of the diagnosis with this system is US$ 70. Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. For instance, Inflammatix, a pioneering molecular diagnostics company, announced the publication of a health economic model that shows the use of the company's HostDxTM Sepsis test is cost-effective as compare to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in Emergency Departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test.

Additionally, in May 2020, Beckman Coulter announced the launch of its new DxH 690T hematology analyzer with early sepsis indicators in the US. The DxH 690T reported accurate results and improved turnaround time by reducing procedural steps and manual touchpoints, making it an ideal solution to help relieve some of sepsis disease burden. Thus, the rising in demand for rapid diagnostics test led to product launches is expected to drive the sepsis diagnostics market during the forecast period.

On the other hand, the lack of skilled professionals hinders market size and growth. Sepsis diagnosis requires laboratory skills and proficiency to process the collection and investigation of the clinical sample. Sepsis is a life-threatening illness that needs to be diagnosed and treated at the earliest with the help of skilled healthcare professionals. The lack of experienced professionals is a significant concern worldwide. For instance, according to an article published in Young Scientist Journal (YSJ) in April 2018, Sub-Saharan Africa faced a critical shortage of healthcare workers. The deficit is due to the declining emigration of healthcare professionals and the lack of proper healthcare infrastructure and medical graduates, which acts as a restraint on the development of the public health system in that region. Sub-Saharan Africa is considered to have the weakest healthcare system globally. Such restrictions are expected to hamper the growth of the global sepsis diagnostics market over the forecast period.

Technology plays a critical role in healthcare diagnostics as it offers accuracy and saves time and resources and therefore, plays a critical role acting as a future trend in sepsis diagnosis. In sepsis diagnosis process, the identification of causative pathogen is essential in selecting appropriate antibiotic therapy as a part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used for sepsis diagnostics techniques. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management. For instance, in October 2020, Immunexpress launched a rapid SeptiCyte, a one-hour molecular diagnostic test for sepsis in Europe on Biocartis' Idylla platform.

Based on product, the sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment led the market in 2021 and is expected to retain its dominance during the forecast period. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points towards further investigations for identifying the focus on infection. A blood culture media is recommended for all sepsis patients. Automation in the blood culture system has enabled maximum yield of pathogens in the shortest possible time to improve patient management and save lives. 30–60% of blood culture media in sepsis become positive. The method is highly recommended as it reveals one of the highest levels of evidence in the diagnostic workup of a sepsis patient. Such factors would support the market growth for the blood culture media segment during the forecast period.

Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexoress, Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; Thermo Fischer Scientific Inc.; bioMerieux Inc.; T2 Biosystems, Inc.; and Axis-Shield Diagnostics Ltd are among the leading companies operating in the sepsis diagnostics market.

The report segments the sepsis diagnostics market as follows:

The sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, and end user. Based on product, the market is segmented into instruments, reagents and assays, blood culture media, and software. Based on technology, the sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. By method, the market is bifurcated into automated diagnostics and conventional diagnostics. By pathogen, the sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. By end user, the market is segmented into hospitals, pathology and reference laboratories, and others.

By geography, the global sepsis diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South and Central America.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Sepsis Diagnostics Market – By Product

1.3.2 Global Sepsis Diagnostics Market – By Technology

1.3.3 Global Sepsis Diagnostics Market – By Method

1.3.4 Global Sepsis Diagnostics Market – By Test Type

1.3.5 Global Sepsis Diagnostics Market – By Pathogen

1.3.6 Global Sepsis Diagnostics Market – By End User

1.3.7 Global Sepsis Diagnostics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Sepsis Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Experts Opinion

5. Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections

5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches

5.2 Market Restraints

5.2.1 Lack of Skilled Professionals

5.3 Market Opportunities

5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research

5.4 Future Trends

5.4.1 Rising Technological Advancements in Sepsis Diagnosis

5.5 Impact Analysis

6. Sepsis Diagnostics Market– Global Analysis

6.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis

6.1.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis

6.1.2 Market Positioning of Key Players

6.1.3 Global Sepsis Diagnostics market – Market Potential Analysis, By Region

6.2 Comparative Company Analysis

6.2.1 Growth Strategy Analysis

6.2.2 Performance of Key Players

6.2.2.1 BioMérieux, Inc.

6.2.2.2 Danaher

6.2.3 Market Share Analysis of Sepsis Diagnostics Market

7. Global Sepsis Diagnostics Market Revenue and Forecasts To 2028– by Product

7.1 Overview

7.2 Global Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)

7.3 Instruments

7.3.1 Overview

7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Reagents and Assays

7.4.1 Overview

7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Blood Culture Media

7.5.1 Overview

7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Software

7.6.1 Overview

7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Technology

8.1 Overview

8.2 Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

8.3 Molecular Diagnostics

8.3.1 Overview

8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Polymerase Chain Reaction

8.3.2.1.1 Overview

8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization

8.3.2.2.1 Overview

8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Syndromic Panel-Based Testing

8.3.2.3.1 Overview

8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.4 Microarrays

8.3.2.4.1 Overview

8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Flow Cytometry

8.4.1 Overview

8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.3 Real-Time Cell Analysis

8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture

8.4.3.1.1 Characteristics of TaqMan Assays

8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) – Case Study

8.4.3.2.1 Abstract

8.4.3.2.2 Conclusion:

8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions

8.4.3.4 Sepsis diagnosis by real-time PCR

8.4.3.5 New next-generation sequencing technique and technological advancements/innovations

8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements

8.4.4 Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Microfluidics

8.5.1 Overview

8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Immunoassay

8.6.1 Overview

8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biomarkers

8.7.1 Overview

8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.3 Metabolomics

8.7.3.1 Metabolite Profile in Sepsis

8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis

8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling

8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis

8.7.3.4.1 Genomics

8.7.3.4.2 Proteomics

8.7.3.5 Sepsis Biomarkers and Diagnostic Tools

8.7.3.6 Role Metabolomics and Proteomics in Sepsis

8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis

8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis

8.7.3.9 Metabolics in Mitochondrial Function

8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine

8.7.4 Metabolomics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Microbiology

8.8.1 Overview

8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Method

9.1 Overview

9.2 Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

9.3 Automated Diagnostics

9.3.1 Overview

9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Conventional Diagnostics

9.4.1 Overview

9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Test Type

10.1 Overview

10.2 Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

10.3 Point-of-Care Tests

10.3.1 Overview

10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4 Laboratory Tests

10.4.1 Overview

10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Pathogen

11.1 Overview

11.2 Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

11.3 Bacterial Sepsis

11.3.1 Overview

11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.4 Fungal Sepsis

11.4.1 Overview

11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.5 Others

11.5.1 Overview

11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Sepsis Diagnostics Market Revenue and Forecasts To 2028 – End User

12.1 Overview

12.2 Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

12.3 Hospitals

12.3.1 Overview

12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.4 Pathology and Reference Laboratories

12.4.1 Overview

12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.5 Others

12.5.1 Overview

12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

13.1 North America: Sepsis Diagnostics Market

13.1.1 Overview

13.1.2 North America: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.1.4 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.4.1 Biomarkers: Metabolomics 2019-2028

13.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.4.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.5 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.6 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.7 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.8 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

13.1.9 North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.1.9.1 US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.9.1.1 Overview

13.1.9.1.2 US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.9.1.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.1.9.1.4 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.9.1.4.1 Biomarkers: Metabolomics 2019-2028

13.1.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.9.1.4.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.9.1.5 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.9.1.6 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.9.1.7 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.9.1.8 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

13.1.9.2 Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.9.2.1 Overview

13.1.9.2.2 Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.9.2.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.1.9.2.4 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.9.2.4.1 Biomarkers: Metabolomics 2019-2028

13.1.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.9.2.4.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.9.2.5 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.9.2.6 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.9.2.7 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.9.2.8 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

13.1.9.3 Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.9.3.1 Overview

13.1.9.3.2 Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.9.3.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.1.9.3.4 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.9.3.4.1 Biomarkers: Metabolomics 2019-2028

13.1.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.9.3.4.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.9.3.5 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.9.3.6 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.9.3.7 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.9.3.8 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

13.2 Europe: Sepsis Diagnostics Market

13.2.1 Overview

13.2.2 Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.3 Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.2.4 Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.2.4.1 Biomarkers: Metabolomics 2019-2028

13.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.2.4.3 Europe: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.2.5 Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.2.6 Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.2.7 Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.2.8 Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.2.9 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.2.9.1 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.1.1 Overview

13.2.9.1.2 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.1.3 Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.2.9.1.4 Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.2.9.1.4.1 Biomarkers: Metabolomics 2019-2028

13.2.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.2.9.1.4.3 Germany: Sepsis Diagnostics Market, by Molecular diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.2.9.1.5 Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.2.9.1.6 Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.2.9.1.7 Germany: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.2.9.1.8 Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.2.9.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.2.1 Overview

13.2.9.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.2.3 France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.2.9.2.4 France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.2.9.2.4.1 Biomarkers: Metabolomics 2019-2028

13.2.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.2.9.2.4.3 France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

13.2.9.2.5 France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.2.9.2.6 France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.2.9.2.7 France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.2.9.2.8 France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.2.9.3 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.3.1 Overview

13.2.9.3.2 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.3.3 UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.2.9.3.4 UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.2.9.3.4.1 Biomarkers: Metabolomics 2019-2028

13.2.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.2.9.3.4.3 UK: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.2.9.3.5 UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.2.9.3.6 UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.2.9.3.7 UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.2.9.3.8 UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.2.9.4 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.4.1 Overview

13.2.9.4.2 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.4.3 Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.2.9.4.4 Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.2.9.4.4.1 Biomarkers: Metabolomics 2019-2028

13.2.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.2.9.4.4.3 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.2.9.4.5 Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.2.9.4.6 Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.2.9.4.7 Italy: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.2.9.4.8 Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.2.9.5 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.5.1 Overview

13.2.9.5.2 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.5.3 Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.2.9.5.4 Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.2.9.5.4.1 Biomarkers: Metabolomics 2019-2028

13.2.9.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.2.9.5.4.3 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.2.9.5.5 Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.2.9.5.6 Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.2.9.5.7 Spain: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

13.2.9.5.8 Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.2.9.6 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.6.1 Overview

13.2.9.6.2 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.2.9.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.2.9.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.2.9.6.4.1 Biomarkers: Metabolomics 2019-2028

13.2.9.6.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.2.9.6.4.3 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.2.9.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.2.9.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.2.9.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.2.9.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.3 Asia Pacific: Sepsis Diagnostics Market

13.3.1 Overview

13.3.2 Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

13.3.3 Asia Pacific: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.3.4 Asia Pacific: Sepsis Diagnostics Market, by Technology, 2019–2028 (USD Million)

13.3.4.1 Biomarkers: Metabolomics 2019-2028

13.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.3.4.3 Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.3.5 Asia Pacific: Sepsis Diagnostics Market, by Method, 2019–2028 (USD Million)

13.3.6 Asia Pacific: Sepsis Diagnostics Market, by Test Type, 2019–2028 (USD Million)

13.3.7 Asia Pacific: Sepsis Diagnostics Market, by Pathogen, 2019–2028 (USD Million)

13.3.8 Asia Pacific: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.3.9 Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.3.9.1 China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.1.1 China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.1.2 China: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.3.9.1.3 China: Sepsis Diagnostics Market, by Technology, 2019–2028 (USD Million)

13.3.9.1.3.1 Biomarkers: Metabolomics 2019-2028

13.3.9.1.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.3.9.1.3.3 China Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.3.9.1.4 China: Sepsis Diagnostics Market, by Method, 2019–2028 (USD Million)

13.3.9.1.5 China: Sepsis Diagnostics Market, by Test Type, 2019–2028 (USD Million)

13.3.9.1.6 China: Sepsis Diagnostics Market, by Pathogen, 2019–2028 (USD Million)

13.3.9.1.7 China: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.3.9.2 Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.2.1 Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.2.2 Japan: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.3.9.2.3 Japan: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.3.9.2.3.1 Biomarkers: Metabolomics 2019-2028

13.3.9.2.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.3.9.2.3.3 Japan Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.3.9.2.4 Japan: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.3.9.2.5 Japan: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.3.9.2.6 Japan: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.3.9.2.7 Japan: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.3.9.3 India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.3.1 India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.3.2 India: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.3.9.3.3 India: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.3.9.3.3.1 Biomarkers: Metabolomics 2019-2028

13.3.9.3.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.3.9.3.3.3 India Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.3.9.3.4 India: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.3.9.3.5 India: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.3.9.3.6 India: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.3.9.3.7 India: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.3.9.4 Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.4.1 Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.4.2 Australia: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.3.9.4.3 Australia: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.3.9.4.3.1 Biomarkers: Metabolomics 2019-2028

13.3.9.4.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.3.9.4.3.3 Australia Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.3.9.4.4 Australia: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.3.9.4.5 Australia: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.3.9.4.6 Australia: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.3.9.4.7 Australia: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.3.9.5 South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.5.1 South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.5.2 South Korea: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.3.9.5.3 South Korea: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.3.9.5.3.1 Biomarkers: Metabolomics 2019-2028

13.3.9.5.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.3.9.5.3.3 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.3.9.5.4 South Korea: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.3.9.5.5 South Korea: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.3.9.5.6 South Korea: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.3.9.5.7 South Korea: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.3.9.6 Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.6.1 Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.3.9.6.2 Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.3.9.6.3 Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.3.9.6.3.1 Biomarkers: Metabolomics 2019-2028

13.3.9.6.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.3.9.6.3.3 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.3.9.6.4 Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.3.9.6.5 Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.3.9.6.6 Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.3.9.6.7 Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts To 2028

13.4.1 Overview

13.4.2 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.4.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.4.4.1 Biomarkers: Metabolomics 2019-2028

13.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.4.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.4.5 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.4.6 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.4.7 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.4.8 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

13.4.9 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

13.4.9.1 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.9.1.1 Overview

13.4.9.1.2 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.9.1.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.4.9.1.4 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.4.9.1.4.1 Biomarkers: Metabolomics 2019-2028

13.4.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.4.9.1.4.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.4.9.1.5 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.4.9.1.6 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.4.9.1.7 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.4.9.1.8 UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

13.4.9.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.9.2.1 Overview

13.4.9.2.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.9.2.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.4.9.2.4 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.4.9.2.4.1 Biomarkers: Metabolomics 2019-2028

13.4.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.4.9.2.4.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.4.9.2.5 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.4.9.2.6 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.4.9.2.7 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.4.9.2.8 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

13.4.9.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.9.3.1 Overview

13.4.9.3.2 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.9.3.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.4.9.3.4 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.4.9.3.4.1 Biomarkers: Metabolomics 2019-2028

13.4.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.4.9.3.4.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.4.9.3.5 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.4.9.3.6 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.4.9.3.7 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.4.9.3.8 South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

13.4.9.4 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.9.4.1 Overview

13.4.9.4.2 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.4.9.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.4.9.4.4 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.4.9.4.4.1 Biomarkers: Metabolomics 2019-2028

13.4.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.4.9.4.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.4.9.4.5 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.4.9.4.6 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.4.9.4.7 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.4.9.4.8 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

13.5 South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028

13.5.1 Overview

13.5.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.5.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.5.4 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.5.4.1 Biomarkers: Metabolomics 2019-2028

13.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.5.4.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.5.5 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.5.6 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.5.7 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.5.8 South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

13.5.9 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

13.5.9.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.5.9.1.1 Overview

13.5.9.1.2 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.5.9.1.3 Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)

13.5.9

LIST OF TABLES.

Table 1. New next-generation sequencing techniques by Company

Table 2. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 3. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 4. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 5. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 6. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 7. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 8. North America Sepsis Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 9. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 10. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 11. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 12. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 13. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 14. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 15. US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 16. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 17. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 18. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 19. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 20. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 21. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 22. Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 23. Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 24. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 25. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 26. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 27. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 28. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 29. Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 30. Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 31. Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 32. Europe: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 33. Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 34. Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 35. Europe: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 36. Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 37. Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 38. Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 39. Germany: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 40. Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 41. Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 42. Germany: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 43. Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 44. France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 45. France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 46. France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 47. France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 48. France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 49. France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 50. France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 51. UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 52. UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 53. UK: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 54. UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 55. UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 56. UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 57. UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 58. Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 59. Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 60. Italy: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 61. Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 62. Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 63. Italy: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 64. Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 65. Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 66. Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 67. Spain: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 68. Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 69. Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 70. Spain: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 71. Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 72. Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 73. Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 74. Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 75. Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 76. Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 77. Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 78. Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 79. Asia Pacific: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 80. Asia Pacific: Sepsis Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 81. Asia Pacific: Sepsis Diagnostics Market, by Method– Revenue and forecast to 2028 (USD Million)

Table 82. Asia Pacific: Sepsis Diagnostics Market, by Test Type– Revenue and forecast to 2028 (USD Million)

Table 83. Asia Pacific: Sepsis Diagnostics Market, by Pathogen – Revenue and forecast to 2028 (USD Million)

Table 84. Asia Pacific: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 85. China: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 86. China: Sepsis Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 87. China: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and forecast to 2028 (USD Million)

Table 88. China: Sepsis Diagnostics Market, by Method– Revenue and forecast to 2028 (USD Million)

Table 89. China: Sepsis Diagnostics Market, by Test Type– Revenue and forecast to 2028 (USD Million)

Table 90. China: Sepsis Diagnostics Market, by Pathogen – Revenue and forecast to 2028 (USD Million)

Table 91. China: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 92. Japan: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 93. Japan: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 94. Japan: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 95. Japan: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 96. Japan: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 97. Japan: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 98. Japan: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 99. India: Sepsis Diagnostics Market, By Product– Revenue and Forecast to 2028(USD Million)

Table 100. India: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 101. India: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 102. India: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 103. India: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 104. India: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 105. India: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 106. Australia: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 107. Australia: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 108. Australia: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 109. Australia: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 110. Australia: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 111. Australia: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 112. Australia: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 113. South Korea: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 114. South Korea: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 115. South Korea: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 116. South Korea: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 117. South Korea: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 118. South Korea: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 119. South Korea: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 120. Rest of Asia Pacific: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 121. Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 122. Rest of Asia Pacific: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 123. Rest of Asia Pacific: Sepsis Diagnostics Market, By Method– Revenue and Forecast to 2028 (USD Million)

Table 124. Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type– Revenue and Forecast to 2028 (USD Million)

Table 125. Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen– Revenue and Forecast to 2028 (USD Million)

Table 126. Rest of Asia Pacific: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 127. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).

Table 128. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 129. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 130. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 131. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 132. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 133. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 134. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 135. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 136. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 137. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 138. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 139. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 140. UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 141. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 142. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 143. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 144. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 145. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 146. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 147. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 148. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 149. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 150. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 151. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 152. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 153. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 154. South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 155. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 156. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 157. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 158. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 159. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 160. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 161. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 162. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 163. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 164. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 165. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 166. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 167. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 168. South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 169. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 170. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 171. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 172. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 173. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 174. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 175. Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 176. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 177. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 178. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 179. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 180. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 181. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 182. Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 183. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 184. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 185. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 186. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 187. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 188. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 189. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 190. Recent Organic Growth Strategies in Sepsis Diagnostics Market

Table 191. Inorganic Developments in the Sepsis Diagnostics Market

Table 192. Glossary of Terms

LIST OF FIGURES.

Figure 1. Sepsis Diagnostics Market Segmentation

Figure 2. Sepsis Diagnostics Market, By Region

Figure 3. Global Sepsis Diagnostics Market Overview

Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Sepsis Diagnostics Market, by Geography (US$ Million)

Figure 7. Global Sepsis Diagnostics Market- Leading Country Markets (US$ Million)

Figure 8. Global Sepsis Diagnostics Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East & Africa: PEST Analysis

Figure 13. South & Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 16. Global Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 17. Global Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 18. Market Positioning of Key Players in Global Sepsis Diagnostics Market

Figure 19. Global Sepsis Diagnostics market – Market Potential Analysis, By Region

Figure 20. Global Sepsis Diagnostics market – Comparative Company Analysis

Figure 21. Global Sepsis Diagnostics Market – Growth Strategy Analysis

Figure 22. Market Share Analysis of Key Players in Global Sepsis Diagnostics Market

Figure 23. Global Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)

Figure 24. Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

Figure 29. Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30. Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32. Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33. Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34. Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35. Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36. Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37. Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 38. Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 39. Metabolomics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40. Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 41. Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

Figure 42. Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 43. Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 44. Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

Figure 45. Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 46. Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 47. Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

Figure 48. Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 49. Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 50. Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 51. Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

Figure 52. Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 53. Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 54. Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 55. North America: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 56. North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 57. North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 58. US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59. Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60. Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61. Europe: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 62. Europe: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 63. Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 64. Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 65. France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 66. UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 67. Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 68. Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 69. Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 70. Asia Pacific: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 71. Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 72. Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 73. China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 74. Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 75. India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 76. Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 77. South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 78. Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 79. Middle East & Africa: Sepsis Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 80. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 81. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 82. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 83. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 84. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 85. Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 86. South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)

Figure 87. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 88. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 89. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 90. Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 91. Rest of South & Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)

Figure 92. Impact of COVID-19 Pandemic in North American Country Markets

Figure 93. Impact of COVID-19 Pandemic in European Country Markets

Figure 94. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 95. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 96. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 97. Growth Strategies in the Sepsis Diagnostics Market (%)

The List of Companies - Sepsis Diagnostics Market

• Abbott

• F. Hoffmann-La Roche Ltd.              

• Immunexpress Inc.             

• BD 

• Danaher

• Luminex Corporation

• Thermo Fisher Scientific Inc.

• bioMerieux SA.

• T2 Biosystems, Inc.

• Axis-Shield Diagnostics Ltd.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the sepsis diagnostics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TOP